Celine Weber

Celine Weber

Managing Associate
MLaw, Avocate

Site

Zurich

Contact

Téléphone direct: +41 58 658 56 17
celine.weber@walderwyss.com

Curriculum Vitae

PDF download

Celine Weber is managing associate in the Healthcare and Life Sciences Team. She is specialized in the regulation of the pharmaceutical and the medtech industry, including the regulation on marketing authorizations and licenses, market access and reimbursement, advertising, product classification, anti-bribery legislation and clinical trials. She also regularly advises on regulatory questions surrounding foodstuffs (including supplements and FSMP), cosmetics and genetic testing.

She has extensive experience representing clients in court proceedings and before administrative authorities in life sciences matters. She also serves as person responsible for pharmaceutical advertising.

Celine Weber is Co-Founder and Board Member of W@LifeSciencesCH. She regularly writes about and gives talks on life sciences law, e.g. on Swiss advertising or anti-bribery legislation.

She studied at the universities of Zurich, Geneva, Paris X Nanterre and New South Wales in Sydney (Master in Life Sciences Law 2012). Before joining Walder Wyss, Celine Weber worked as a court clerk at the District Court in Meilen and as a trainee lawyer at a major corporate law firm in Zurich. Furthermore, she worked as an in-house counsel at an international pharmaceutical company.

Celine Weber speaks German, English, French and Norwegian. She has been admitted to the Bar Association of the Canton of Zurich and is authorized to conduct legal proceedings throughout Switzerland.

Stepping into the future: A closer look at the third revision oft the Therapeutic Products Act (TPA / HMG)

Swiss pharmaceutical reimbursement and pricing: Ordinance Law Changes (KVV/KLV) as of January 2024: Today's Decision by the Swiss Federal Council (Bundesrat)

Triennial review of medicines’ SL prices: Lessons learned from appeals won against the FOPH

QR codes for medicines – new guidance

Food for Special Medical Purposes (FSMP): New specific CJEU requirements

Genetic Testing – An Overview of the New Provisions

Pharmaceutical Advertising 2022 - Switzerland

The Life Sciences Law Review Capitolo 24 - Svizzera

Pubblicità farmaceutica – Svizzera

The Life Sciences Law Review Chapter 28 - Switzerland

Lebensmittel- und Gebrauchsgegenständerecht

L'étiquetage et la promotion des denrées alimentaires et des objets usuels

Handbook on Foodstuffs and Utility Articles law

Life Science Law Update

Life Science Law Update

Life Science Law Update

Life Science Law Update

Più trasparenza in Swissmedic

Life Science Law Update

The Life Sciences Law Review - Capitolo 29: Svizzera

Pubblicità farmaceutica – Svizzera

La sigaretta elettronica nel diritto svizzero

Le sigarette elettroniche contenenti nicotina nel diritto svizzero

Qualificazione dei “cerotti frequenziali” come dispositivi medici